Bide Pharmatech Co. Ltd. A Financial Flexibility Index
Bide Pharmatech Co. Ltd. A financial flexibility index. Bide Pharmatech Co. Ltd. A (688073) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of CN¥52.61 Million (operating CF CN¥28.32 Million minus capex CN¥24.28 Million) represents 0% of total liabilities (CN¥471.40 Million). Explore 688073 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Bide Pharmatech Co. Ltd. A (2020–2025)
Financial flexibility index of Bide Pharmatech Co. Ltd. A from 2020 to 2025. Historical Financial Flexibility Index trend for Bide Pharmatech Co. Ltd. A across 6 annual periods. Check cash flow reinvestment rate of Bide Pharmatech Co. Ltd. A to assess the company's total reinvestment commitment from operating cash flow.
Bide Pharmatech Co. Ltd. A Financial Flexibility Index by Year (2020–2025)
Bide Pharmatech Co. Ltd. A financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Bide Pharmatech Co. Ltd. A. For the full cash flow conversion analysis, see Bide Pharmatech Co. Ltd. A (688073) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | CN¥52.61 Million | CN¥28.32 Million | CN¥471.40 Million | ▼ -82.3% |
| 2024 | 0.63x | CN¥246.66 Million | CN¥158.31 Million | CN¥390.91 Million | ▲ +5464.4% |
| 2023 | 0.01x | CN¥3.69 Million | CN¥-57.39 Million | CN¥325.49 Million | ▼ -95.3% |
| 2022 | 0.24x | CN¥68.28 Million | CN¥29.87 Million | CN¥283.05 Million | ▲ +287.5% |
| 2021 | -0.13x | CN¥-35.68 Million | CN¥-64.88 Million | CN¥277.27 Million | ▼ -152.1% |
| 2020 | 0.25x | CN¥41.37 Million | CN¥3.65 Million | CN¥167.64 Million | — |